SCIEX announces the 7th Berliner LC-MS/MS Symposium
SCIEX has announced it will be holding the 7th LC-MS/MS Symposium in Berlin, Germany, on March 14th 2017. The Symposium includes a diverse programme of talks about the latest mass spectrometry methods and applications, from internationally respected researchers and analytical scientists. There will also be training courses available to users on March 13th. The conference programme and online registration are now available.
The Symposium includes a plenary session that will focus on trends and new developments in mass spectrometry, followed by an afternoon of talks divided into six parallel themes. These themes are: food analysis, environmental and drinking water analysis, clinical chemistry, pharmaceutical analysis, toxicology and forensics, and biochemistry and omics applications. Speakers include Prof Gérard Hopfgartner, University of Geneva, Switzerland; Prof Jens Brockmeyer, Stuttgart University, Germany; Dr Wolfgang Schulz, Zweckverband Landeswasserversorgung, Stuttgart; Prof Mario Thevis, Sport University Cologne; Dr Torsten Binscheck-Domaß, Labor Berlin, and a number of other high profile scientists. The Symposium will also feature a small exhibition with stands from life science companies, as well as a poster session and two discussion rounds on the day after the Symposium.
The Symposium has grown in popularity since the first conference, with over 600 attendees at the last meeting. The 7th Berliner LC-MS/MS Symposium will take place at the Estrel Hotel Berlin, and is open for mass spec users as well as life science journalists to attend.
This article has been republished from materials provided by Sciex Note: material may have been edited for length and content. For further information, please contact the cited source.
Rapid Removal of Arsenic From Drinking Water...By Moss!News
A moss capable of removing arsenic from contaminated water has been discovered by researchers. And it happens quickly – in just one hour, the arsenic level is so low that the water is no longer harmful for people to drink.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.